眼缺血综合征研究进展

doi:10.6040/j.issn.1673-3770.1.2020.059

山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (4): 23-27.doi: 10.6040/j.issn.1673-3770.1.2020.059

• 眼缺血综合征多学科精准诊疗专家笔谈 • 上一篇下一篇

眼缺血综合征研究进展

王露萍综述黄映湘,王艳玲审校

王露萍综述黄映湘, 王艳玲审校首都医科大附属北京友谊医院眼科, 北京 100050

收稿日期:2020-06-21 出版日期:2020-07-20 发布日期:2020-08-28
基金资助:
国家自然科学基金资助(81870686);首都卫生发展科研专项资助(首发2018-1-2021)doi:106040/jissn1673-377012020059·专家笔谈·眼缺血综合征研究进展王露萍综述

Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:

Key words:Ocular ischemic syndrome;
Fluorescein angiography;
Optical coherence tomography angiography;
Cell therapy眼缺血综合征(ocular ischemic syndrome, OIS)是由同侧颈总动脉或颈内动脉狭窄或阻塞导致眼动脉(视网膜中央动脉及睫状前/后动脉)低灌注, 而产生一系列脑部和眼部症状的慢性进行性眼病。1963年Hedges^［1］首次报道颈内动脉闭塞患者不仅存在对侧肢体运动及感觉障碍, 并且合并一系列眼部症状, 如一过性黑矇、视物模糊等。除此之外, Hedges观察到此类患者视网膜存在静脉扩张和周边点片状出血, 由此提出颈动脉供血不足引起视网膜缺血缺氧的理论基础。OIS起病隐匿, 眼部表现复杂多样, 且容易被其他眼血管疾病掩盖, 如糖尿病性视网膜病变和视网膜静脉阻塞等, 因此临床上容易漏诊或误诊, 导致患者不可逆的视力丧失, 5年死亡率高达40%, 患者大多死于心肌梗死和脑梗死等心脑血管事件^［2-3］。因此, OIS需要眼科、神经科和心脏病科等多学科综合诊疗, 通过大规模临床研究, 建立OIS医学数据库, 进一步规范多学科诊疗流程, 对于降低患者的患盲率和死亡率是至关重要的。

Received:2020-06-21 Online:2020-07-20 Published:2020-08-28

摘要/Abstract

摘要： 眼缺血综合征起病隐匿,眼部表现多样,临床上易被漏诊或误诊从而导致患者不可逆的视力丧失,且合并眼缺血综合征患者远期心脑血管疾病死亡风险较高。提高各学科临床医生对眼缺血综合征的认知和诊疗水平有助于发挥多学科交叉协同作用,预防和早期发现血管性疾病的危险因素和全身性并发症,降低致盲率和致死率。本文就眼缺血综合征的流行病学、临床表现以及诊疗措施的最新研究进展进行综述。

关键词: 眼缺血综合征, 荧光血管造影, 光学相干断层扫描血管成像, 干细胞治疗

Abstract: Ocular ischemic syndrome(OIS)is usually undiagnosed or misdiagnosed due to its asymptomatic onset, complicated ocular manifestations, and the lack of awareness, and patients with OIS have a higher mortality. Improving the understanding, diagnosis, and treatment of OIS through multidisciplinary collaboration is key to investigating and preventing systemic vascular events as well as decreasing blindness and mortality. This review summarizes the recent advances in the epidemiology, clinical diagnosis, and management of OIS.

Key words: Ocular ischemic syndrome, Fluorescein angiography, Optical coherence tomography angiography, Cell therapy

中图分类号:

R771.3

王露萍综述黄映湘, 王艳玲审校. 眼缺血综合征研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 23-27.

Ocular ischemic syndrome(OIS)is usually undiagnosed or misdiagnosed due to its asymptomatic onset, complicated ocular manifestations, and the lack of awareness, and patients with OIS have a higher mortality. Improving the understanding, diagnosis, and treatment of OIS through multidisciplinary collaboration is key to investigating and preventing systemic vascular events as well as decreasing blindness and mortality. This review summarizes the recent advances in the epidemiology, clinical diagnosis, and management of OIS.. Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 23-27.

参考文献 40

[1]	Hedges TR Jr. Ophthalmoscopic findings in internal carotid artery occlusion[J]. Am J Ophthalmol, 1963, 55: 1007-1012.
[2]	LuoJY, Yan ZC, Jia Y, et al. Clinical analysis of 42 cases of ocular ischemic syndrome[J]. J Ophthalmol, 2018, 2018: 2606147. doi:10.1155/2018/2606147.
[3]	Karacostas D, Terzidou C, Voutas S, et al. Isolated ocular ischemic syndrome with no cerebral involvement in common carotid artery occlusion[J]. Eur J Ophthalmol, 2001, 11(1): 97-101. doi:10.1177/1120672101011-00121.
[4]	Hung JH, Chang YS. Ocular ischemic syndrome[J]. Can Med Assoc J, 2017, 189(23): E804. doi:10.1503/cmaj.160459.
[5]	Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features[J]. IntOphthalmol, 1988, 11(4): 239-251. doi:10.1007/BF00131023.
[6]	Benjankar M, Sitaula S, Karki P. Ocular ischemic syndrome; A case report[J]. Nepal J Ophthalmol, 2019, 11(21): 86-90. doi:10.3126/nepjoph.v11i1.25434.
[7]	Kearns TP, Siekert RG, Sundt TM. The ocular aspects of carotid artery bypass surgery[J]. Trans Am OphthalmolSoc, 1978, 76: 247-265.
[8]	Anguita R, Nazar C, Kobus R, et al. Bilateral ocular ischemic syndrome as a manifestation of Takayasu arteritis in children[J]. Can J Ophthalmol, 2019, 54(3): e105-e108. doi:10.1016/j.jcjo.2018.08.018.
[9]	Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome—a systematic review[J]. Med SciMonit, 2012, 18(8): RA138-RA144. doi:10.12659/msm.883260.
[10]	Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome[J]. Ophthalmology, 1997, 104(5): 859-864. doi:10.1016/s0161-6420(97)30221-8.
[11]	Klijn CJ, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome[J]. Stroke, 2002, 33(3): 695-701. doi:10.1161/hs0302.104619.
[12]	Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment[J]. Int Ophthalmol, 1991, 15(1): 15-20. doi:10.1007/BF00150974.
[13]	López Sánchez E, Francés Muñoz E, Mondéjar García JJ, et al. Anterior pole ischemia and carotid stenosis[J]. Arch Soc Esp Oftalmol, 2000, 75(6):421-424.
[14]	Michelson PE, Knox DL, Green WR. Ischemic ocular inflammation. A clinicopathologic case report[J]. Arch Ophthalmol, 1971, 86(3): 274-280. doi:10.1001/archopht.1971.01000010276007.
[15]	Kim YH, Sung MS, Park SW. Clinical features of ocular ischemic syndrome and risk factors for neovascularGlaucoma[J]. Korean J Ophthalmol, 2017, 31(4): 343-350. doi:10.3341/kjo.2016.0067.
[16]	Mendrinos E, MacHinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. SurvOphthalmol, 2010, 55(1): 2-34. doi:10.1016/j.survophthal.2009.02.024.
[17]	Sharma S. Ophthaproblem. Ocular ischemic syndrome[J]. Can Fam Physician, 1999, 45: 901, 909.
[18]	Battista M, Borrelli E, Sacconi R, et al. Optical coherence tomography angiography in diabetes: a review[J]. Eur J Ophthalmol, 2020, 30(3): 411-416. doi:10.1177/1120672119899901.
[19]	Pellegrini M, Vagge A, Ferro Desideri LF, et al. Optical coherence tomography angiography in neurodegenerative disorders[J]. J Clin Med, 2020, 9(6): E1706. doi:10.3390/jcm9061706.
[20]	Rao HL, Pradhan ZS, Suh MH, et al. Optical coherence tomography angiography in Glaucoma[J]. J Glaucoma, 2020, 29(4): 312-321. doi:10.1097/ijg.000000000-0001463.
[21]	Balaratnasingam C, Inoue M, Ahn S, et al. Visual acuity is correlated with the area of the fovealavascular zone in diabetic retinopathy and retinal vein occlusion[J]. Ophthalmology, 2016, 123(11): 2352-2367. doi:10.1016/j.ophtha.2016.07.008.
[22]	Yang S, Liu XQ, Li H, et al. Optical coherence tomography angiography characteristics of acute retinal arterial occlusion[J]. BMC Ophthalmol, 2019, 19(1): 147. doi:10.1186/s12886-019-1152-8.
[23]	Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human Retina by projection-resolved optical coherence tomography angiography[J]. Sci Rep, 2017, 7: 42201. doi:10.1038/srep42201.
[24]	Saito K, Akiyama H, Mukai R. Alteration of optical coherence tomography angiography in a patient with ocular ischemic syndrome[J]. Retin Cases Brief Rep, 2019. doi:10.1097/ICB.0000000000000857.
[25]	Choi EY, Lee SC, Kim M. Optical coherence tomography angiography before and after bevacizumabinjection in ocular ischemic syndrome[J]. Retina(Philadelphia, Pa), 2018, 38(3): e23-e25. doi:10.1097/IAE.0000000000001981.
[26]	Kawaguchi S, Okuno S, Sakaki T, et al. Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery Stenosis[J]. Neurosurgery, 2001, 48(2): 328-332; discussion 322-3. doi:10.1097/00006123-200102000-00016.
[27]	Nederkoorn PJ, van der Graaf Y,Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery Stenosis: a systematic review[J]. Stroke, 2003, 34(5): 1324-1332. doi:10.1161/01.STR.0000068367.08991.A2.
[28]	Koelemay MJ, Nederkoorn PJ, Reitsma JB, et al. Systematic review of computed tomographic angiography for assessment of carotid artery disease[J]. Stroke, 2004, 35(10): 2306-2312. doi:10.1161/01.STR.0000141426.63959.cc.
[29]	Marx JL, Hreib K, Choi IS, etal. Percutaneous carotid artery angioplasty and stenting for ocular ischemic syndrome[J]. Ophthalmology, 2004, 111(12): 2284-2291. doi:10.1016/j.ophtha.2004.05.029.
[30]	Abraham S, Feucht N, Lohmann CP, et al. Ocular ischemic syndrome[J]. Ophthalmologe, 2015, 112(8): 679-681. doi:10.1007/s00347-014-3178-x.
[31]	Franco-Cardenas V, Shah SU, Apap D, et al. Assessment of ischemic index in retinal vascular diseases using ultra-wide-field fluorescein angiography: single versus summarized image[J]. SeminOphthalmol, 2017, 32(3): 353-357. doi:10.3109/08820538.2015.1095304.
[32]	Arai N, Sasahara A, Hagiwara S, et al. Immediate improvement of ischemic oculopathy after stenting for internal carotid artery stenosis[J].Brain Nerve, 2014, 66(12):1503-1508. doi: 10.11477/mf.1416200065.
[33]	Amselem L, Montero J, Diaz-Llopis M, et al. Intravitreal bevacizumab(Avastin)injection in ocular ischemic syndrome[J]. Am J Ophthalmol, 2007, 144(1):122-124. doi:10.1016/j.ajo.2007.02.037.
[34]	Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists(EURETINA)[J]. Ophthalmologica, 2017, 237(4):185-222. doi:10.1159/000458539.
[35]	Mansour SE, Browning DJ, Wong K, Flynn HW Jr, Bhavsar AR. The Evolving Treatment of Diabetic Retinopathy[J].Clin Ophthalmol, 2020,14:653-678. Published 2020 Mar 4. doi:10.2147/OPTH.S236637.
[36]	Amoroso F, Pedinielli A, Astroz P, et al. Comparison of pain experience and time required for pre-planned navigated peripheral laser versus conventional multispot laser in the treatment of diabetic retinopathy[J]. Acta Diabetol, 2020, 57(5):535-541. doi:10.1007/s00592-019-01455-x.
[37]	Bertelli PM, Pedrini E, Guduric-Fuchs J, et al. Vascular regeneration for ischemic retinopathies: hope from cell therapies[J]. Curr Eye Res, 2020, 45(3): 372-384. doi:10.1080/02713683.2019.1681004.
[38]	Park SS, Moisseiev E, Bauer G, et al. Advances in bone marrow stem cell therapy for retinal dysfunction[J]. Prog Retin Eye Res, 2017, 56:148-165. doi:10.1016/j.preteyeres.2016.10.002.
[39]	Fiori A, Terlizzi V, Kremer H, et al. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy[J]. Immunobiology, 2018, 223(12): 729-743. doi:10.1016/j.imbio.2018.01.001.
[40]	Park SS. Cell Therapy Applications for Retinal Vascular Diseases: Diabetic Retinopathy and Retinal Vein Occlusion[J]. Invest Ophthalmol Vis Sci, 2016, 57(5):ORSFj1-ORSFj10. doi:10.1167/iovs.15-17594.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

眼缺血综合征研究进展

Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 10

多维度评价

本文评价

推荐阅读 10

[1]	黄映湘, 王艳玲. 正确判读眼缺血综合征预警信号,提高诊断水平[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 1-4.
[2]	徐泽勤综述郭连瑞审校. 颈动脉狭窄诊疗进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 11-15.
[3]	孟博,黄映湘,王康,赵露,王艳玲. 眼缺血综合征国内外文献特征分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 35-40.
[4]	郭欣璐,高健生,接传红. 中医药联合激光及手术治疗眼缺血综合征一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 48-52.
[5]	秦书琪,王露萍,姜彬,王艳玲. 眼缺血综合征并发新生血管性青光眼一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 53-55.
[6]	傅强,王红星. 眼缺血综合征患者脉络膜厚度的分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 60-63.
[7]	杨秀芬,李红阳,赵露,魏莹,胡向东,陈珺,王艳玲. 眼缺血综合征的临床及影像学特点分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 119-123.
[8]	贺艳艳，肖淑烽，董彩蓉. 荧光素眼底血管造影后不良反应的影响因素[J]. 山东大学耳鼻喉眼学报, 2012, 26(5): 75-76.
[9]	张奕霞，杨炜，邱明磊，陈宁宁. 重度Ⅱ型视盘血管炎的早期全光凝治疗[J]. 山东大学耳鼻喉眼学报, 2012, 26(4): 66-68.
[10]	王菁洁1，魏锐利2，金玲1. B超等影像检查在脉络膜血管瘤诊断中的应用[J]. 山东大学耳鼻喉眼学报, 2010, 24(6): 70-.